期刊文献+

血清脂联素与糖尿病视网膜病变关系的研究 被引量:2

Study on association of serum adiponectin levels with diabetic retinopathy
下载PDF
导出
摘要 目的研究血清脂联素水平与泰安汉族人2型糖尿病视网膜病变之间的关系。方法用放射免疫法(R IA)检测泰安地区111例无亲缘关系汉族人空腹血清脂联素浓度。正常对照者35例(正常对照组);2型糖尿病患者76例(2型糖尿病组),其中无糖尿病视网膜病变组(NDR)27例,非增殖性糖尿病视网膜病变组(NPDR)28例,增殖性糖尿病视网膜病变组(PDR)21例。结果进行统计学分析。结果 2型糖尿病组血清脂联素水平明显地低于正常对照组(P<0.001);PDR组脂联素浓度明显地低于NDR或NPDR组(P<0.001)。结论血清脂联素水平在泰安地区汉族2型糖尿病人中是降低的,脂联素浓度与糖尿病视网膜病变严重程度相关,脂联素可能在糖尿病视网膜病变的发病机制中发挥作用,对判断病情、指导治疗、估计预后均有一定意义。 Objective: To investigate the association of serum adiponectin levels with type 2 Diabetes Mellitus(DM) in the Han population.Methods: Radioimmunoassay technique was used to determine the serum adiponectin concentration in 76 unrelated type 2 DM and 35 normal control subjects in Taian region.The patients were stratified into three subgroups according to the stage of diabetic retinopath including 27 patients without any retinopathy(NDR),28 patients with non-proliferative diabetic retinopathy(NPDR) and 21 patients with proliferative diabetic retinopathy(PDR).Results: The adiponectin concentration was significantly decreased in the DM group,and the adiponectin concentration in the PDR group was significantly lower than that in NDR or NPDR.Conclusion: The results show that adiponectin concentrations are lower in patients with type 2 DM and associated with the severity of diabetic retinopathy.
出处 《泰山医学院学报》 CAS 2010年第11期824-827,共4页 Journal of Taishan Medical College
关键词 2型糖尿病 脂联素 糖尿病视网膜病变 type 2 diabetes adiponectin diabetic retinopathy
  • 相关文献

参考文献6

  • 1Yamauchi T,Kamon J,Minokoshi Y,et al.Adiponectin stimulates glucose utilization and fatty-acid oxidation by activatingAMP-actived protein Kinase[J].Nature Med,2002,8(11):1288-1295.
  • 2Ouchi N,Kihara S,Arita Y,et al.Novel modulator for endothelial adhesion molecules:adipocyte-derived plasma protein adiponectin[J].Circulation,1999,100(11):2473-2476.
  • 3Ouchi N,Kihara S,Arita Y,et al.Adipocyte-derived plasma protein,adiponectin,suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages[J].Circulation,2001,103(10):1057-1063.
  • 4Hotta K,Funahashi T,Arita Y,et al.Plasma concentrations of a novel,adiposespecific protein,adiponectin,in type 2 diabetic patients[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2000,20:1595-1599.
  • 5Arita Y,Kihara S,Ouchi N,et al.Paradoxical decrease of an adipose-specific protein,adiponectin,in obesity[J].Biochemical and Biophysical Research Communications,1999,257(6):79-83.
  • 6Adamczak M,Wiecek A,Funahashi T,et al.Decreased plasma adiponectin concentration in patients with essential hypertension[J].American Journal of Hypertension,2003,16(5):72-75.

同被引文献20

  • 1陈雪,石晓聪,曹晓华,等.游离脂肪酸水平92型糖尿病及糖尿病性视网膜病变的关系[J].中外医学研究,2013,11(23):191.
  • 2Wilkinson-Berka JL, Tan G, Jaworski K, et al. Valsartan but not Atenolol improves vascular pathology in diabetic Ren-2 rat retina[l]. Am l Hypertension, 2007, 20(4): 423-430.
  • 3Sultan MB, Zhou D, Loftus J, et al. A phase 2/3, multicenter, randomized, double-masked, 2 -year trial of pegaptanib sodium fbr the treatment of diabetic macular edema[J]. Ophthalmology, 2011, 118(6): 1107-1118.
  • 4Cunningham El', Adamis AP, Altaweel M, et al. A phase ll randomized double-masked trial of pegaptanib,an anti-vascular endothelial growth factor aptamer, tbr diabetic macular edema[J]. Ophthalmology, 2005, 112(10): 1747-1757.
  • 5Ishikawa K,Honda S,Tsukahara Y, et al. Preferable use of intravitreaJ bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy[J]. Eye(Lond, England), 20/)9, 23( 1 ): 108-111.
  • 6Nonaka A, Kiryu J, Tsujikawa A, et al. Inhibitory effect of ischemic preconditioning on leukocyte participation in retinal ischemia-reperfusion injury[J]. Invest Ophthalmol Vis Sci, 2001, 42(10): 2380-2385.
  • 7Aiello LP, Davis MD, Girach A, et al. Effect of Ruboxistaurin on visual loss in patients with diabetic retinopatby[J]. Ophthalmology, 2006, 113(12) : 2221-2230.
  • 8Jonas J, Heatley G, Spaide R, et al. lntravitreal triamcino lone acetonide and secondary ocular hypertension[J]. J Glaucoma, 2005, 14(2): 168-171.
  • 9Massin E Audren F, Haouchine B, et al. lntravitreal triamcinoloneacetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial[J]. Ophthalmology, 2004, 111 (2): 218-224.
  • 10杜中良,王慎田.血清护骨素水平与2型糖尿病视网膜病变的关系[J].山东医药,2009,49(3):80-81. 被引量:3

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部